XML 21 R5.htm IDEA: XBRL DOCUMENT v3.23.2
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss, Net of Taxes
Retained Earnings
Balance, beginning of period (in shares) at Oct. 31, 2021   67.3      
Balance, beginning of period at Oct. 31, 2021   $ 0.7 $ 750.9 $ (22.5) $ 880.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0.6      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 (9.4)    
Repurchase of common stock (in shares) (1.7) (1.7)      
Share-based compensation expense     24.4    
Repurchase of common stock $ (74.5) $ 0.0 (74.5)    
Other comprehensive income (loss)       (10.7)  
Net income 181.6       181.6
Dividends          
Common stock ($0.220 and $0.195 per share)         (39.0)
Stock issued under share-based compensation plans         (1.3)
Balance, end of period (in shares) at Jul. 31, 2022   66.1      
Balance, end of period at Jul. 31, 2022 $ 1,680.3 $ 0.7 691.4 (33.3) 1,021.4
Balance, beginning of period (in shares) at Apr. 30, 2022   66.8      
Balance, beginning of period at Apr. 30, 2022   $ 0.7 716.4 (25.2) 977.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0.1      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 (1.3)    
Repurchase of common stock (in shares) (0.7) (0.7)      
Share-based compensation expense     7.5    
Repurchase of common stock $ (31.2) $ 0.0 (31.2)    
Other comprehensive income (loss)       (8.1)  
Net income 56.8       56.8
Dividends          
Common stock ($0.220 and $0.195 per share)         (12.9)
Stock issued under share-based compensation plans         (0.2)
Balance, end of period (in shares) at Jul. 31, 2022   66.1      
Balance, end of period at Jul. 31, 2022 1,680.3 $ 0.7 691.4 (33.3) 1,021.4
Balance, beginning of period (in shares) at Oct. 31, 2022   65.6      
Balance, beginning of period at Oct. 31, 2022 $ 1,717.2 $ 0.7 675.5 (16.2) 1,057.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0.6      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 (10.0)    
Repurchase of common stock (in shares) (0.6) (0.6)      
Share-based compensation expense     22.2    
Repurchase of common stock $ (27.1) $ 0.0 (27.1)    
Other comprehensive income (loss)       14.1  
Net income 188.5       188.5
Dividends          
Common stock ($0.220 and $0.195 per share)         (43.5)
Stock issued under share-based compensation plans         (1.3)
Balance, end of period (in shares) at Jul. 31, 2023   65.5      
Balance, end of period at Jul. 31, 2023 $ 1,860.1 $ 0.7 660.7 (2.2) 1,201.0
Balance, beginning of period (in shares) at Apr. 30, 2023   66.1      
Balance, beginning of period at Apr. 30, 2023   $ 0.7 679.2 (14.6) 1,117.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued under employee stock purchase and share-based compensation plans (in shares)   0.0      
Stock issued (taxes withheld) under employee stock purchase and share-based compensation plans, net   $ 0.0 0.9    
Repurchase of common stock (in shares) (0.6) (0.6)      
Share-based compensation expense     7.6    
Repurchase of common stock $ (27.1) $ 0.0 (27.1)    
Other comprehensive income (loss)       12.4  
Net income 98.1       98.1
Dividends          
Common stock ($0.220 and $0.195 per share)         (14.5)
Stock issued under share-based compensation plans         (0.2)
Balance, end of period (in shares) at Jul. 31, 2023   65.5      
Balance, end of period at Jul. 31, 2023 $ 1,860.1 $ 0.7 $ 660.7 $ (2.2) $ 1,201.0